ArticlePharmacoEconomics2005

Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.

Eduardo Carracedo-MartínezPubMed ↗Publisher ↗

No numbers read from the abstract.